|
221 |
Qu L.G., Perera M., Lawrentschuk N., Umbas R., Klotz L. |
57204687809;56544134500;57217501609;6602634832;55040556500; |
Scoping review: hotspots for COVID-19 urological research: what is being published and from where? |
2021 |
World Journal of Urology |
39 |
9 |
|
3151 |
3160 |
|
2 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090474581&doi=10.1007%2fs00345-020-03434-2&partnerID=40&md5=02d48bd6f6edec3e634ad6f1c71c4628 |
Olivia Newton John Cancer Research Institute, Austin Health, Melbourne, VIC, Australia; Department of Surgery, University of Melbourne, Melbourne, VIC, Australia; Department of Urology, Austin Health, Heidelberg, VIC, Australia; Department of Urology, The Royal Melbourne Hospital, Melbourne, VIC, Australia; EJ Whitten Prostate Cancer Research Centre at Epworth, Melbourne, VIC, Australia; Department of Urology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada |
Qu, L.G., Olivia Newton John Cancer Research Institute, Austin Health, Melbourne, VIC, Australia, Department of Surgery, University of Melbourne, Melbourne, VIC, Australia, Department of Urology, Austin Health, Heidelberg, VIC, Australia; Perera, M., Olivia Newton John Cancer Research Institute, Austin Health, Melbourne, VIC, Australia, Department of Surgery, University of Melbourne, Melbourne, VIC, Australia; Lawrentschuk, N., Department of Surgery, University of Melbourne, Melbourne, VIC, Australia, Department of Urology, The Royal Melbourne Hospital, Melbourne, VIC, Australia, EJ Whitten Prostate Cancer Research Centre at Epworth, Melbourne, VIC, Australia; Umbas, R., Department of Urology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Klotz, L., Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada |
Purpose: Contemporary, original research should be utilised to inform guidelines in urology relating to the COVID-19 pandemic. This comprehensive review aimed to: identify all up-to-date original publications relating to urology and COVID-19, characterise where publications were from, and outline what topics were investigated. Methods: This review utilised a search strategy that assessed five electronic databases, additional grey literature, and global trial registries. All current published, in-press, and pre-print manuscripts were included. Eligible studies were required to be original research articles of any study design, reporting on COVID-19 or urology, in any of study population, intervention, comparison, or outcomes. Included studies were reported in a narrative synthesis format. Data were summarised according to primary reported outcome topic. A world heatmap was generated to represent where included studies originated from. Results: Of the 6617 search results, 48 studies met final inclusion criteria, including 8 pre-prints and 7 ongoing studies from online registries. These studies originated from ten countries according to first author affiliation. Most studies originated from China (n = 13), followed by Italy (n = 12) and USA (n = 11). Topics of the study included pathophysiological, administrative, and clinical fields: translational (n = 14), COVID-19-related outcomes (n = 5), urology training (n = 4), telemedicine (n = 7), equipment and safety (n = 2), urology in general (n = 4), uro-oncology (n = 3), urolithiasis (n = 1), and kidney transplantation (n = 8). Conclusion: This review has outlined available original research relevant to COVID-19 and urology from the international community. This summary may serve as a guide for future research priorities in this area. © 2020, Springer-Verlag GmbH Germany, part of Springer Nature. |
COVID-19; Kidney transplantation; Telemedicine; Training; Uro-oncology; Urology |
epidemiology; global health; human; kidney transplantation; medical research; oncology; organization and management; prevention and control; procedures; publishing; telemedicine; urology; Biomedical Research; COVID-19; Global Health; Humans; Kidney Transplantation; Medical Oncology; Publishing; SARS-CoV-2; Telemedicine; Urology |
Springer Science and Business Media Deutschland GmbH |
07244983 |
|
32909171 |
Article |
Q1 |
1552 |
2143 |
|
|
